Category Archives: Blogs

AZBio Blogs

National LambdaRail appoints Crow as head of Chairman’s Advisory Council

Posted on by
September 14, 2011

Patrick Soon-Shiong, chairman and CEO of National LambdaRail, announced the appointment of ASU President Michael M. Crow as head of a new Chairman’s Advisory Council.Aided by a $100 million guarantee from the Chan Soon-Shiong Institute for Advanced Health to upgrade and extend its network to support big science projects, the council will help guide the new mission of National LambdaRail, the 12,000-mile-high-performance communications network linking the nation’s leading research institutions.Continue reading→

Regenesis Biomedical takes to the stage at the AdvaMed 2011 MedTech

Posted on by

Regenesis Biomedical to Participate in the AdvaMed 2011 MedTech Conference:  Selected to present in the Wound Management category and serve as a panelist on Emerging Growth Companies.

Scottsdale, Arizona, September 5, 2011 — Regenesis Biomedical, Inc., a medical technology company focused on regenerative medicine, announced today that it was selected to present at the AdvaMed 2011 MedTech conference. Regenesis presents in the Wound Management category. The aim of the conference is to connect companies that have an innovative medical technology to parties interested in investing capital, partnering, or initiating strategic alliances.Continue reading→

NAU researcher thrust into the maelstrom after 9/11

Posted on by

ERIC BETZ Sun Staff  Reporter   azdailysun.com  |  Monday, September 12, 2011

On the morning of September 11, 2001, Paul Keim was out for a run with his  dog on Observatory Mesa, oblivious to the events unfolding along the eastern  seaboard.

He was training for a marathon that he would never run.

Within weeks, he would be sitting on the hood of his Toyota on the tarmac at  Flagstaff Pulliam Airport when a blonde woman walked off a Gulfstream jet and  handed him a package.

“Dr. Keim, this is the anthrax,” she told him.   Read more at the Arizona Daily Sun   

Study: Medical Device Tax Could Cost Jobs, Stifle Innovation

Posted on by

WASHINGTON,D.C. –The medical device tax, if implemented, could cost tens of thousands of jobs, almost double the industry’s total taxes, raise the effective tax rate to among the highest in the world, and harm U.S. competiveness, according to a study released today by the Advanced Medical Technology Association (AdvaMed).  The new study, “Employment Effects of the New Excise Tax on the Medical Device Industry,” by Manhattan Institute senior fellow Diana Furchtgott-Roth and Hudson Institute senior fellow Harold Furchtgott-Roth, outlines a number of economic harms likely to result from the tax.Continue reading→

Intrinsic Bioprobes, Inc. Acquired by Thermo Fisher

Posted on by

Thermo Fisher Scientific Inc., the world leader in serving science, announced on September 1, 2011  that it has enhanced its workflow for biomarker research and diagnostics by acquiring Tempe, Arizona based  Intrinsic Bioprobes Inc., a manufacturer of unique immuno-enrichment, sample-preparation tools used in quantitative mass spectrometry. The Intrinsic Bioprobes portfolio enables Thermo Fisher to offer its worldwide life science research and clinical diagnostics customers an enhanced solution for quantitative protein biomarker detection.

Continue reading→

Tips on Writing Powerful Public Comment Letters Regarding Proposed Regulations

Posted on by

By: Michael T. Hull – Managing Director, InVent Life Sciences   mhull@inventls.com  (Former Regional Advocate for the U.S. SBA Office of Advocacy)

The federal government proposes and finalizes approximately 4,000 new rules every year. In general approximately 800-1,000 will directly affect small business. A 2008 study by the U.S. Small Business Administration’s Office of Advocacy estimated that the cost of complying with federal rules and regulations exceeds $1.75 trillion per year with small businesses spending approximately 36% more per employee than their large business counterparts.Continue reading→

Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding to Advance its High Throughput Screening Platform

Posted on by

TUCSON, AZ – LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker™ technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.

Continue reading→

The FDA When There’s An App For That

Posted on by

There is a lot happening on the medical device front these days around MDDS (Medical Device Data Systems) and the FDA is paying close attention with new regulations, guidance and requests for comment. 

With the  April 2012 compliance deadline less than 8 months away, AZBio Member John C. Hoffman of QMR is paying close attention too and keeping our community in the loop via the AZBio  Resource Network Group on LinkedIn.  If you and your team are working in the MDDS space, you’ll want to get connected and join the discussion.

Continue reading→